RACHEL GOODE: Open Payments
NPI 1710427760 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 29 payments from 10 companies in 2025. Trend: 2023 $335 · 2024 $716 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $143 |
| Novo Nordisk Inc | 4 | $88 |
| Lilly USA, LLC | 4 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| PFIZER INC. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Exact Sciences Corporation | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, PREVNAR 20, Ozempic, GVOKE HYPOPEN, MOUNJARO, ZEPBOUND, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
